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Abstract 
 
BACKGROUND: Lack of financial incentive is a frequently cited barrier to alcohol screening 
in primary care.  The Quality and Outcomes Framework (QOF) pay for performance scheme 
has reimbursed UK primary care practices for alcohol screening in people with schizophrenia 
since April 2011.  This study aimed to determine the impact of financial incentives on alcohol 
screening by comparing rates of alcohol recording in people with versus those without 
schizophrenia between 2000 and 2013. 
 
METHODS: Cross-sectional and retrospective cohort study.  Alcohol data were extracted 
from The Health Improvement Network (THIN) database of UK primary care records using 1) 
Read Codes for level of alcohol consumption, 2) continuous measures of drinking (e.g. units 
a week), and 3) Read Codes for types of screening test.  
 
RESULTS:  
A total of 14,860 individuals (54% (8,068) men and 46% (6,792) women) from 409 general 
practices aged 18-99 years with schizophrenia were identified during April 2011 to March 
2013.  Of these, 11,585 (78%) had an alcohol record, of which 99% (8,150/8,257) of Read 
codes for level of consumption were eligible for recompense in the QOF.  There was a 839% 
increase in alcohol recording among people with schizophrenia over the 13 year period (rate 
ratio per annum increase 1.19 (95% CI 1.18 to 1.20)), compared with a 62% increase among 
people without a severe mental illness (rate ratio per annum increase 1.04 (95% CI 1.03 to 
1.05)). 
 
CONCLUSION: Financial incentives offered by the QOF appear to have a substantial impact 
on alcohol screening among people with schizophrenia in UK primary care.   
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Short summary 
Alcohol screening among people with schizophrenia increased dramatically in primary health 
care following the introduction of the UK pay for performance incentive scheme (Quality and 
Outcomes Framework - QOF) for severe mental illness, with an 839% rise (more than 8-fold 
increase), compared with a 62% increase among people without a severe mental illness 
over the 13 year study period (2000 – 2013). 
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Introduction 
Alcohol screening and brief intervention is an example of an efficacious intervention that has 
attempted, yet failed to be routinely delivered in primary health care across the world.  There 
are three decades of research to support the use of alcohol screening and brief intervention 
in primary care, where brief intervention is an umbrella term that encompasses interventions 
that range from brief structured advice through to motivational interviewing.  Alcohol 
screening and brief intervention is advocated by the WHO global strategy to reduce harmful 
use of alcohol (World Health Organisation, 2010), the WHO comprehensive mental health 
action plan 2013–2020 (World Health Organisation, 2013), and by UK NICE guidance (NICE 
public health guidance 24, 2010).  However, as few as 2% of risky drinkers are identified in 
UK primary care (Cheeta et al., 2008), and national survey data has shown that 6.5% of 
risky drinkers recall GP advice on their drinking, compared with 50% of smokers who recall 
GP advice on smoking cessation (Brown et al., 2016).  In addition, when alcohol screening 
does take place in primary care, it is rarely with WHO validated screening tools (Khadjesari 
et al., 2013).  There is a vast literature on the barriers to implementing alcohol screening and 
brief intervention in primary care (Johnson et al., 2011; Nilsen et al., 2006), with lack of 
financial incentive one of the key obstacles (Adams et al., 1997; Babor et al., 2005). 
 
Pay for performance schemes are widespread in the UK and US, with financial incentives a 
recognised implementation / quality improvement strategy in health care systems (Powell et 
al., 2015).  However, despite their widespread use, there is mixed evidence for their impact 
on quality of care, with few methodologically robust evaluations, such as interrupted time 
series or controlled before-and-after studies with contemporaneous control groups (Houle et 
al., 2012; Scott et al., 2011).  The largest and most recent randomised controlled trial to 
explore the impact of implementation strategies for alcohol screening and brief interventions 
in 120 primary care practices in five European countries (ODHIN) found financial incentives 
combined with training and support to be most effective at improving rates of screening and 
brief intervention, compared with 1) treatment as usual, 2) training and support, 3) financial 
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reimbursement alone, 4) electronic screening and brief intervention, and combinations of 
these interventions (Anderson et al., 2016; Keurhorst et al., 2013).  Moreover, financial 
incentives were found to be the most cost-effective of these implementation strategies, with 
incentive and delivery costs amounting to £110 million over 10 years, but leading to £250 
million of savings to the NHS and saving 33,000 Quality Adjusted Life Years (QALYs) 
(Angus et al., 2014).   
 
The Quality and Outcomes Framework (QOF), a pay for performance scheme, was 
introduced to primary care in the UK in 2004 to encourage best practice, currently in 19 
clinical areas (including severe mental illness (SMI)) and six public health areas (British 
Medical Association. NHS England. NHS Employers, 2014).  At present, there is no QOF 
incentive for universal alcohol screening of all registered patients, but there are QOF 
incentives for alcohol screening in specific subgroups of the population such as people with 
schizophrenia, where median prevalence of alcohol use disorders is 9.4% (interquartile 
range 4.6–19.0) and lifetime prevalence is 20.6% (interquartile range 12.0–34.5) (Koskinen 
et al., 2009).  In April 2006, the QOF for severe mental illness (including schizophrenia, 
bipolar affective disorder and other psychoses) was amended to provide additional 
incentives for health screening (Indicator MH9) (British Medical Association. NHS 
Employers, 2006), replaced in April 2011 with additional incentives for specific components 
of the health screen, including alcohol screening (Indicator MH11), Body Mass Index, blood 
pressure, cholesterol and blood glucose (British Medical Association. NHS Employers, 
2011).  A recent study based in one inner-city London Borough with 30 General Practices 
found that the introduction of a local version of QOF that incentivised alcohol screening and 
brief intervention for patients with severe mental illness, cardiovascular disease, or risk or 
cardiovascular disease, increased recording of alcohol intake in patients with severe mental 
illness from 0.65% (95% CI 0.49% to 0.81%) to 48.6% (95% CI 47.8% to 49.4%) (Hamilton 
et al., 2014).  Interestingly, a small improvement in alcohol screening was also found in 
patients without a severe mental illness, cardiovascular disease, or risk of cardiovascular 
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disease from 0.32% (CI 0.29% to 0.36%) to 14.7% (CI 14.5% to 14.9%).  This regional study 
provides some insight into the impact of financial incentives on alcohol consumption 
recording in primary care, but to-date there has been no investigation into their impact at a 
national level.  
 
Aims 
To determine the extent to which alcohol consumption is recorded in people with 
schizophrenia and other psychoses in primary care, whether recording varies by socio-
demographics, registration status and geographic region, and to compare rates of alcohol 
consumption recording in people with and without schizophrenia between 2000 and 2013.   
 
Objectives 
1. To describe how alcohol consumption has been recorded in individuals with schizophrenia 
and other psychoses in primary care, e.g. use of Read codes, quantity measures, screening 
tests. 
 
2. To describe how the recording of alcohol consumption in individuals with schizophrenia 
and other psychoses varies by socio-demographic factors (age, sex, and social deprivation), 
by registration status, and by region (previous strategic health authority for England and 
country for Wales, Scotland, and Northern Ireland).  
 
3. To evaluate the impact of QOF incentives by comparing rates of alcohol consumption 
recording over time in individuals with versus without schizophrenia and other psychoses: 
April 2000 to March 2004 (before the SMI QOF), April 2004 to March 2006 (SMI QOF 
introduced), April 2006 to March 2011 (addition of lifestyle screening to the SMI QOF 
indicators), April 2011 to March 2013 (addition of alcohol screening to the SMI QOF 
indicators).   
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Methods  
Study design 
Cross-sectional study and retrospective cohort study. 
 
Data source  
The Health Improvement Network (THIN) (The Health Improvement Network, 2012) is a 
primary care database containing anonymised electronic patient records from over 500 
general practices, covering approximately 6% of the UK population and broadly 
representative in terms of age, sex, deprivation, and geographical distribution (Blak et al., 
2011).  Information is entered in primary care as free text or Read Codes, a hierarchical 
coding system standardised across all UK general practices (Chisholm, 1990; Dave and 
Petersen, 2009).  THIN includes information about year of birth, gender and the Townsend 
deprivation index, which is a composite measure of social deprivation presented as quintiles 
(Townsend et al., 1988).  Data from individual practices were included in this study if 
collected after the Acceptable Mortality Reporting (Maguire et al., 2009) and Acceptable 
Computer Usage dates (Horsfall et al., 2013); these are quality standards to ensure that data 
were acceptable for analyses.  Acceptable mortality reporting is a validation of the mortality 
data recorded at the practice.  Acceptable computer usage is measured by the number of 
clinical entries made on the computer systems.  The scheme for THIN to obtain and provide 
anonymous patient data to researchers was approved by the National Health Service South-
East Multicenter Research Ethics Committee in 2002.  The scientific approval for this study 
was obtained from the Scientific Review Committee of Cegedim Strategic Data (CSD) 
Medical Research (the THIN database providers) in January 2015 (15-005). 
 
Participant eligibility 
The severe mental illness QOF relates to people with schizophrenia, bipolar affective 
disorder and other psychoses.  Patients with bipolar disorder were excluded from these 
studies and explored by the research team in a separate analysis (Hardoon et al., 2016).   
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Cross-sectional study (objectives 1 and 2): Individuals aged between 18 and 99 years with a 
diagnosis of schizophrenia and other psychoses, registered with a THIN practice throughout 
April 2011 to March 2013, were included in the cross sectional study.  Individuals with a 
diagnosis of schizophrenia and other psychoses were identified via relevant Read Codes in 
their electronic primary care health records, as used in a recent study of recording of severe 
mental illness in primary care (Hardoon et al., 2013).   
 
Retrospective cohort study (objective 3): we expanded the study sample to include 
individuals registered for at least some part of the period April 2000 to March 2013.  A 
separate cohort of individuals without a SMI was randomly selected among those of the 
same gender, practice, and age-band (18-29, 30-49, 50-69 and 70-99 years).  For every one 
individual with schizophrenia, six individuals without a SMI were selected in-line with a 
similar study of cardiovascular screening in individuals with severe mental illness (Osborn et 
al., 2011).   
 
Alcohol measures in THIN  
1) Read Codes that reflect levels of drinking were selected.  The codes were selected from 
those used in three recent studies of alcohol consumption recording in primary care 
(Hamilton et al., 2014; Khadjesari et al., 2013; O'Donnell, 2014).  These Read Codes 
typically represent a drinking category, for example moderate drinker 3–6 units a day, but 
also include codes that indicate drinking above limits; for example, harmful drinking.   
 
2) Data on alcohol consumption as a continuous measure of the number of units consumed 
in a week were extracted.   
 
The above measures were also used to summarise the proportion of people with 
schizophrenia drinking at harmful levels (defined as a Read code indicative of heavy 
  
9 
 
drinking/ alcohol problem or a record of >35 units per week for women and >50 units per 
week men) (Department of Health, 2008; Prime Minister's Strategy Unit, 2004).   
 
3) Read Codes that indicate the types of screening tool used were also included to 
determine how many people had completed a validated screening test.  Results from 
validated screening tests are sometimes entered as free text and therefore not extractable 
for this study.   
 
Analysis  
To describe how alcohol consumption has been recorded in individuals with schizophrenia 
and other psychoses in primary care (objective 1), we computed the numbers of individuals 
with schizophrenia, registered with a practice between April 2011 and March 2013, who had 
Read codes for level of drinking and screening tests, and quantity measures for alcohol 
consumption during this period.   
 
To describe how the recording of alcohol consumption in individuals with schizophrenia and 
other psychoses varies by socio-demographic factors, registration status and region 
(objective 2), the proportions of men and women with schizophrenia with an alcohol record 
between April 2011 and March 2013 and relative “risk” of recording of alcohol were 
presented by socio-demographic factors (age, sex, social deprivation), registration status 
and geographic region.  Poisson regression was chosen here to enable computation of risk 
ratios as opposed to odds ratios to aid interpretation (Davies et al., 1998).  Relative “risks” 
were obtained from Poisson regression with robust standard errors to account for clustering 
of individuals within general practices.  Random effects regression modelling, with 
individuals nested in general practices, was used to examine the extent of practice variation 
in alcohol recording (Cameron et al., 2013). 
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To evaluate the impact of QOF incentives in individuals with versus without schizophrenia 
and other psychoses (objective 3), eligible individuals entered the retrospective cohort study 
at the latest of: registration, practice Acceptable Computer Usage and Acceptable Mortality 
Reporting date, 1 April 2000, 18th birthday, schizophrenia diagnosis date (or schizophrenia 
diagnosis date of matched individual with schizophrenia, among those without 
schizophrenia).  Individuals left the study at the earliest of: date of death, when they leave 
the practice, the practice leaves THIN, 31 March 2013, or they reach 100 years of age.  
Rates of alcohol consumption recording were computed among those with and without 
schizophrenia during every two financial years follow-up period, between 1st April 2000 and 
31 March 2013.  Rates of alcohol consumption records in individuals with schizophrenia 
were compared with individuals without schizophrenia using Poisson regression, with robust 
standard errors to take into account potential clustering within practices.  An interaction 
between schizophrenia status (yes or no) and calendar period (as a categorical variable, 
with categories for each two financial year period) was included to assess whether variations 
in recording among individuals with versus without schizophrenia have changed over time, in 
particular according to the four time periods described above.  Poisson regression was 
chosen here as it enables proper treatment /accounting of the varying person-time each 
individual contributed to the analysis.  Further, Poisson regression was appropriate for this 
time-trend analysis given the limited number of time-points (six two-yearly periods, reflecting 
the reporting periods of QOF), which makes alternative time-series analysis unsuitable.  
Age, gender, deprivation and UK region were included as covariates.  All analyses were 
conducted in STATA version 13 (StataCorp., 2013). 
 
Results 
Recording of alcohol consumption in people with schizophrenia in primary care 
In total, 14,860 individuals from 409 general practices aged 18-99 years with schizophrenia 
(or other psychoses) were identified throughout the period 1 April 2011 to 31 March 2013.  
There were 8,068 men (54%) and 6,792 (46%) women.  The mean ages (standard 
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deviation) at the start of the period were 40 years (19.4) and 49 years (19.6) for men and 
women respectively.  There was a median of 32 individuals (interquartile range 20 to 48) 
with a record of schizophrenia per general practice.  Out of the 14,860 individuals, 881 (6%) 
were “newly registered” at the start of the period (i.e. had registered with the practice in the 
year prior to the period).  The proportion of people with schizophrenia drinking at higher risk / 
harmful levels was 21% (1,658/8,068) in men and 10% (655/6,792) in women.  There was 
considerable variation in recording levels between general practices, ranging from 42% to 
100% (p<0.001 for practice level variation from random effects regression modelling).   
 
Out of the 14,860 individuals, 11,585 (78%) had a relevant alcohol consumption record 
during this period, with data recorded as a Read Code for units in a week (only) (5,985, 
52%), units of alcohol in a week (only) (3,151, 27%), a Read Code for type of screening test 
used (only) (38, 0.33%), or more than one of these methods of recording (2,411, 21%) 
(Figure 1).  Of the 8,257 records comprising Read codes for alcohol consumption, 8,150 
(99%) were codes found in the Quality and Outcomes Framework for severe mental illness 
business rules (QOF for SMI) (The NHS Information Centre - QOF Business Rules team, 
2011).  Appendix 1 and 2 list the Read codes used in this study to indicate level of alcohol 
consumption and screening test administered, respectively.   
 
Recording of alcohol consumption in people with schizophrenia by socio-demographic 
factors, registration status and region 
Over 80% (5,435/6,664) of individuals aged 50–79 years had an alcohol consumption 
record, compared with 67% (650/978) of men and 72% (320/445) of women under the age of 
30 (Table 1).  The proportion of people with an alcohol consumption record in the least 
deprived quintile was 75% (1,371/1,840), compared with around 80% (3,318/4,136) in the 
most deprived quintile for both men and women (Table 1).  There was also a statistically 
significant regional variation in alcohol consumption recording (overall p-values comparing 
all regions of p=0.02 and p=0.003 among men and women respectively, indicative of some 
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differences between regions).  Recording rates appeared highest in London and lowest in 
the East Midlands (Table 1).  There were no statistically significant differences in recording 
levels by registration status. 
 
Impact of the severe mental illness QOF on alcohol consumption recording over time 
Between April 2000 and April 2013, there were 34,440 individuals with schizophrenia or 
other psychoses and 226,984 individuals without a severe mental illness identified as a 
matched cohort; a total of 261,424 individuals from 484 general practices.  There were a 
median of 162 (interquartile range: 89 to 264) individuals with schizophrenia or other 
psychoses and 1167 (interquartile range: 624 to 1908) individuals without a severe mental 
illness per general practice.  Table 2 provides demographic characteristics of people with 
and without schizophrenia.  Rates of alcohol recording increased rapidly over time among 
those with schizophrenia or other psychoses (Table 3 and Figure 2).  In contrast, there 
appears to be only a modest increase in recording rates among individuals without a severe 
mental illness over time.  Prior to April 2004, rates of alcohol recording among those 
individuals with schizophrenia or other psychoses were on par with or lower than those 
among individuals without a severe mental illness (rate ratios of 0.89 and 0.99) (Table 3), but 
after April 2004, were higher, with the gap widening over time (rate ratio of 1.34 in April 2004 
to March 2006 to a rate ratio of 3.80 in the most recent time period). 
 
Among individuals with schizophrenia or other psychoses, the alcohol recording rate ratio 
per annum increase in calendar time was 1.19 (95% CI 1.18 to 1.20), corresponding to a 
total percentage increase over the 13 year period of 839% (more than 8-fold increase).  By 
contrast, among individuals without a severe mental illness, the alcohol recording rate ratio 
per annum increase in calendar time was 1.04 (95% CI 1.03 to 1.05), corresponding to a 
total percentage increase over the 13 year period of 62%.  The difference in the time trends 
in alcohol recording between individuals with and without schizophrenia was statistically 
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significant (p<0.001 for interaction between time period and patient group: with and without 
schizophrenia) 
 
Discussion 
The majority of individuals with schizophrenia and other psychoses included in this study 
had an alcohol consumption record (78%, 11,585/14,860).  Around 21% (1,658/8,068) of 
men and 10% (655/6,792) of women with schizophrenia were recorded as drinking at higher 
risk / harmful levels.  Alcohol consumption recording varied statistically significantly by age, 
deprivation and region. Highest levels of recording were observed among those aged 
between 50 and 79 years, those with highest levels of deprivation and in London.  Further 
analyses are needed to confirm differences between age categories, deprivation quintiles 
and regions to explore possible explanations for the differences.  The recording of alcohol 
consumption increased dramatically following the introduction of the severe mental illness 
QOF, with an 839% rise (more than 8-fold increase) over the 13 year period.  The most 
substantial rise occurred after the introduction of the indicator for alcohol consumption 
recording in April 2011.   
 
This study found recording of alcohol consumption in primary care to occur in 78% of 
individuals with schizophrenia and other psychoses (April 2011 to March 2013), rising to 
86% when individuals with exemption records were excluded.  Perhaps unsurprisingly, 99% 
of Read codes used to record alcohol consumption in the current study were those provided 
in the severe mental illness QOF business rules (The NHS Information Centre - QOF 
Business Rules team, 2011), thereby enabling financial reimbursement.  Conversely, in a 
study of alcohol consumption recording in newly registered patients in UK primary care, the 
codes necessary for recompense by a different pay for performance scheme (i.e. the 
Directed Enhanced Service) were rarely used – 9% (25,975/292,376) of patients completed 
a validated screening test, such as the AUDIT, AUDIT-C or the FAST (Khadjesari et al., 
2013).  The most plausible explanation for this finding is that the incentive offered by the 
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Directed Enhanced Service was substantially lower than that offered by the QOF (£2.38 per 
patient vs. £133.76 per point (up to 4 QOF points) in 2012/2013 respectively), and therefore 
has less influence on practitioner behaviour.   
 
The Directed Enhanced Service pay for performance scheme, which ran from April 2008 to 
April 2014, was an attempt to broaden the delivery of alcohol screening in primary care to a 
population level, by incentivising alcohol screening among newly registered patients.  A 
study of 16 primary care practices in North East England found better rates of alcohol 
screening and brief intervention recording in practices receiving Directed Enhanced Service 
incentives versus those not receiving incentives between 2010 and 2011 (3.73%, 95% CI: 
3.65-3.89 vs 0.05%, 95% CI: 0.03-0.08; p <0.001) (O'Donnell, 2014).  However, the national 
primary care data analysed in the current study found no statistically significant differences 
in alcohol recording by registration status, again suggesting that the magnitude of the 
incentive reflects the degree of uptake of the activity.  These findings are reinforced by a 
qualitative interview study with general practitioners, which found QOF incentives to be given 
priority above other incentive schemes because of their substantial contribution to practice 
income (O'Donnell, 2014).  If alcohol screening is to be delivered at a population level, QOF 
incentives should be extended to all patient groups, especially in-light of their cost 
effectiveness relative to other implementation strategies (Angus et al., 2014). 
 
The QOF has been criticised for incentivising recording practice, rather than quality of care, 
and is considered a move in the opposite direction from holistic, patient-centred practice that 
promotes self-management (Dixon et al., 2010).  As a result, primary care practice is now 
seen as being task oriented, and where one-activity supersedes another, may result in 
detrimental effects on the quality of care for non-targeted patients.  However, despite the 
failings of the QOF in this regard, it does appear to have an impact on alcohol consumption 
screening among patients with schizophrenia in this study.  This is an important finding as 
these patients have high rates of harmful drinking compared with the general population: 
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21% men and 10% women with schizophrenia (2011-2013) vs. 1% men and 0.5% women 
who were newly registered with a UK general practice (2007-2009) (Khadjesari et al., 2013).  
It is important to note that the QOF indicator only provides recompense for the recording of 
alcohol consumption among patients with SMI and does not incentivise provision of 
treatment, leading to uncertainty over the extent to which patients with schizophrenia are 
supported in reducing their drinking.  NICE guidance on the assessment and management of 
psychosis with substance misuse advocates the referral of patients identified in primary care 
to secondary care mental health services for assessment and further management (National 
Collaborating Centre for Mental Health (UK), 2011).  Psychosocial treatment is advocated for 
patients drinking at harmful and dependent levels without severe mental illness (NICE 
clinical guidance 115, 2011), however, there is no evidence that psychosocial treatment 
(including assertive community outreach, intensive case management, motivational 
interviewing, cognitive behavioural therapy, contingency management or social skills 
training) reduces alcohol consumption or improves mental health in people with severe 
mental illness (Hunt et al., 2013), with most trials of poor methodological quality.  Hunt et al’s 
Cochrane review calls for robust research that uses validated outcome measures of clinical 
relevance to enable synthesis in future meta-analyses.  Hunt et al also recommend that 
future trials evaluate brief interventions due to their potential cost-effectiveness and ease of 
integration within mental health services (Hunt et al., 2013). 
 
Strengths and limitations  
This is the first study to look at the impact of the severe mental illness QOF on alcohol 
consumption recording among people with schizophrenia in a large nationally representative 
sample of individuals from general practices in the UK.  Data on alcohol status in primary 
care rely on self-report in the absence of a gold standard approach to ascertaining alcohol 
intake.  Self-report is the most widely used means of eliciting drinking behaviour in research 
with non-dependent drinkers, providing a valid, reliable and feasible approach when 
compared with biochemical markers, coverage of sales data and collateral reports (Connors 
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and Maisto, 2003; Del Boca and Darkes, 2003; Midanik, 1988; Rehm, 1998).  Finally, 
although we have data on whether an individual has completed a validated alcohol 
screening test, the results per se were not known, as they were recorded in the free text.  
Some of these results may be proxied as Read codes or number of units consumed in a 
week.  However, it is important to determine the extent to which primary care practitioners 
are using validated tests to record alcohol consumption.   
 
Implications 
Our findings suggest that the financial incentives provided by the alcohol indicator of the 
severe mental illness QOF appear to have had a substantial impact on alcohol consumption 
recording among people with schizophrenia in primary care.  Further research is needed to 
better inform the evidence base on interventions for patients with schizophrenia identified as 
drinking at higher risk levels. 
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Table 1: Proportions of men and women with a relevant alcohol record during the period 
April 2011-March 2013 and relative “risk” of recording of alcohol by demographic group 
  MEN     WOMEN     
  Records/N (%) RR (95% CI) p Records/N (%) RR (95% CI) p 
All 6247/8068 (77.4) 
 
  5338/6792 (78.6) 
  Age, years             
18-29 650/978 (66.5) 0.85 (0.81 to 0.89)   320/445 (71.9) 0.92 (0.86 to 0.98) 
 30-39 1278/1737 (73.6) 0.94 (0.90 to 0.97)   641/836 (76.7) 0.98 (0.94 to 1.03) 
 40-49 1655/2109 (78.5) 1   1072/1380 (77.7) 1 
 50-59 1243/1504 (82.6) 1.06 (1.02 to 1.10)   1155/1442 (80.1) 1.03 (0.99 to 1.07) 
 60-69 896/1089 (82.3) 1.05 (1.02 to 1.09)   1002/1251 (80.1) 1.04 (0.99 to 1.08) 
 70-79 406/489 (83.0) 1.07 (1.02 to 1.12)   733/889 (82.5) 1.07 (1.02 to 1.11) 
 80-89 112/151 (74.2) 0.97 (0.88 to 1.06)   363/476 (76.3) 0.99 (0.93 to 1.05) 
 90-99 7/11 (63.6) 0.81 (0.51 to 1.27)   52/73 (71.2) 0.92 (0.8 to 1.06) 
 
 
  
 
<0.001 
  
<0.001 
Deprivation quintile*             
1 (Least deprived) 646/867 (74.5) 0.94 (0.89 to 0.98)   725/973 (74.5) 0.93 (0.88 to 0.98) 
 2 858/1121 (76.5) 0.96 (0.92 to 1.00)   849/1083 (78.4) 0.98 (0.94 to 1.02) 
 3 1157/1543 (75.0) 0.94 (0.90 to 0.98)   1094/1411 (77.5) 0.97 (0.93 to 1.01) 
 4 1605/2054 (78.1) 0.98 (0.95 to 1.01)   1333/1672 (79.7) 0.99 (0.96 to 1.03) 
 5 (Most deprived) 1981/2483 (79.8) 1   1337/1653 (80.9) 1 
 
 
  
 
0.01 
  
0.05 
UK region+             
London 874/1063 (82.2) 1   753/897 (83.9) 1 
 East Midlands 68/100 (68.0) 0.83 (0.62 to 1.12)   70/117 (59.8) 0.72 (0.49 to 1.06) 
 East of England 366/472 (77.5) 0.95 (0.88 to 1.03)   297/378 (78.6) 0.95 (0.87 to 1.04) 
 West Midlands 481/625 (77) 0.94 (0.87 to 1.02)   462/570 (81.1) 0.97 (0.92 to 1.04) 
 North East 150/190 (78.9) 0.95 (0.88 to 1.04)   124/152 (81.6) 0.97 (0.89 to 1.05) 
 North West 845/1084 (78.0) 0.95 (0.89 to 1.01)   681/863 (78.9) 0.95 (0.89 to 1.00) 
 Yorkshire & Humber 75/98 (76.5) 0.92 (0.82 to 1.03)   62/87 (71.3) 0.85 (0.62 to 1.16) 
 Northern Ireland 341/423 (80.6) 0.98 (0.91 to 1.05)   304/363 (83.7) 1.00 (0.94 to 1.07) 
 Scotland 988/1269 (77.9) 0.93 (0.88 to 0.99)   789/1002 (78.7) 0.94 (0.89 to 0.99) 
 South Central 675/869 (77.7) 0.96 (0.90 to 1.02)   637/801 (79.5) 0.96 (0.92 to 1.01) 
 South East Coast 432/595 (72.6) 0.89 (0.83 to 0.95)   389/528 (73.7) 0.89 (0.83 to 0.95) 
 South West 461/643 (71.7) 0.87 (0.82 to 0.93)   390/549 (71.0) 0.86 (0.79 to 0.93) 
 Wales 491/637 (77.1) 0.94 (0.88 to 1.00)   380/485 (78.4) 0.94 (0.88 to 1.00) 
 
 
  
 
0.02 
  
0.003 
Registration status             
Not newly registered 5846/7531 (77.6) 1   5072/6448 (78.7) 1 
 Newly registered 401/537 (74.7) 0.98 (0.93 to 1.03)   266/344 (77.3) 0.99 (0.93 to 1.06) 
       0.4     0.9 
*Deprivation measured using Townsend score +UK region (former Strategic Health Authorities in England, plus Scotland, Wales 
and N Ireland). RR = Relative risk, estimated from Poisson regression, adjusting for the other factors considered and for accounting 
for clustering of people within general practices 
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Table 2: Baseline demographic characteristics in people with and without schizophrenia 
2000-2013 
  
People with 
schizophrenia 
People without 
schizophrenia 
Total individuals 34,440 226,984 
 
N (%) N (%) 
Gender     
Men 18,540 (53.8) 123,543 (54.4) 
Women 15,900 (46.2) 103,441 (45.6) 
   Age, years     
18-29 6,274 (18.2) 43,151 (19.0) 
30-49 13,627 (39.6) 89,457 (39.4) 
50-69 9,299 (27.0) 59,138 (26.1) 
70-99 5,240 (15.2) 35,238 (15.5) 
   Townsend deprivation quintile   
1 (Least deprived) 4,427 (12.9) 49,243 (21.7) 
2 5,252 (15.3) 46,676 (20.6) 
3 6,872 (20.0) 48,729 (21.5) 
4 8,678 (25.2) 45,989 (20.3) 
5 (Most deprived) 9,211 (26.8) 36,347 (16.0) 
   UK region   
London 4,351 (12.6) 27,908 (12.3) 
East Midlands 1,353 (3.9) 9,060 (4.0) 
East of England 2,380 (6.9) 15,803 (7.0) 
West Midlands 2,587 (7.5) 17,201 (7.6) 
North East 1,005 (2.9) 6,646 (2.9) 
North West 4,083 (11.9) 26,827 (11.8) 
Yorkshire & Humber 1,429 (4.2) 9,147 (4.0) 
Northern Ireland 1,221 (3.6) 7,769 (3.4) 
Scotland 4,071 (11.8) 26,231 (11.6) 
South Central 3,902 (11.3) 26,059 (11.5) 
South East Coast 2,614 (7.6) 17,430 (7.7) 
South West 3,274 (9.5) 22,381 (9.9) 
Wales 2,170 (6.3) 14,522 (6.4) 
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Table 3: Alcohol recording rates and adjusted rate ratios comparing people with and without schizophrenia within each time period 
  
Individuals 
with 
Schizophrenia 
and 
psychoses        
Individuals 
without 
Schizophrenia 
and 
psychoses           
Time period N 
Total 
person 
years 
No. with 
alcohol 
record 
Rate of alcohol 
recording per 1000 
person-years (95% CI) N 
Total 
person 
years 
No. with 
alcohol 
record 
Rate of alcohol 
recording per 1000 
person-years (95% CI) 
Adjusted Rate 
ratio* (95% CI) - 
cases v controls p 
1 Apr 2000 - 31 Mar 2002 9,033 15,177 1,241 81.8 (77.3 to 86.4) 54,198 93,656 8,339 89.0 (87.1 to 91.0) 0.89 (0.84 to 0.96) 0.001 
1 Apr 2002 - 31 Mar 2004 12,303 19,650 3,043 154.9 (149.5 to 160.5) 78,869 129,750 19,675 151.6 (149.5 to 153.8) 0.99 (0.95 to 1.03) 0.6 
1 Apr 2004 - 31 Mar 2006 15,617 22,436 5,099 227.3 (221.1 to 233.6) 106,136 169,080 27,571 163.1 (161.2 to 165.0) 1.34 (1.28 to 1.41) <0.001 
1 Apr 2007 - 31 Mar 2009 18,128 25,313 7,306 288.6 (282.1 to 295.3) 136,277 219,761 34,050 154.9 (153.3 to 156.6) 1.79 (1.69 to 1.89) <0.001 
1 Apr 2009 - 31 Mar 2011 19,229 24,265 9,025 371.9 (364.3 to 379.7) 151,126 234,391 40,034 170.8 (169.1 to 172.5) 2.09 (1.96 to 2.22) <0.001 
1 Apr 2011 - 31 Mar 2013 19,545 18,701 13,515 722.7 (710.6 to 735.0) 159,097 243,134 44,826 184.4 (182.7 to 186.1) 3.80 (3.54 to 4.08) <0.001 
                      
*Adjusted rate ratio comparing people with bipolar disorder to people without severe mental illness, from Poisson regression adjusting for age, gender, deprivation, UK region  and accounting for 
clustering of people in general practices 
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Figure 1: Types of alcohol records among people with schizophrenia in April 2011-March 
2013 
 
 
  
 Venn Diagram
 N = 11585
 
 Read code for alcohol screen 
 Record of units per week
 Read code for level of alcohol consumed
 139  3151 38
 167
 5985
 244  1861
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Figure 2: Graph of alcohol recording rates over time, people with and without schizophrenia 
 
 
 
KEY: Solid black line = men with schizophrenia; Dashed black line = women with schizophrenia; Solid grey line = men without 
schizophrenia; Dashed grey line = women without schizophrenia.  Spikes with caps are 95% confidence interval 
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Appendix 1 
Read codes for level of alcohol consumed, and frequency of use among people with 
schizophrenia in April 2011-March 2013 
  
Read code Description 
In 
QOF?* N 
1361.00 Teetotaller Yes 3603 
1367.00 Stopped drinking alcohol Yes 1690 
1362.11 Drinks rarely Yes 871 
1362.12 Drinks occasionally Yes 745 
1362.00 Trivial drinker - <1u/day Yes 309 
1361.11 Non drinker alcohol Yes 181 
1363.00 Light drinker - 1-2u/day Yes 154 
1364.00 Moderate drinker - 3-6u/day Yes 135 
136L.00 Alcohol intake within recommended sensible limits Yes 132 
E23..00 Alcohol dependence syndrome No 59 
1365.00 Heavy drinker - 7-9u/day Yes 51 
136K.00 Alcohol intake above recommended sensible limits Yes 48 
1361.12 Non-drinker alcohol Yes 43 
1366.00 Very heavy drinker - >9u/day Yes 33 
136R.00 Binge drinker Yes 27 
E23..12 Alcohol problem drinking No 25 
136T.00 Harmful alcohol use Yes 24 
136J.00 Social drinker Yes 19 
136D.00 Ex-heavy drinker - (7-9u/day) Yes 14 
136S.00 Hazardous alcohol use Yes 12 
136C.00 Ex-moderate drinker - (3-6u/d) Yes 10 
136O.00 Moderate drinker Yes 10 
136P.00 Heavy drinker Yes 10 
136N.00 Light drinker Yes 8 
136B.00 Ex-light drinker - (1-2u/day) Yes 6 
136E.00 Ex-very heavy drinker-(>9u/d) Yes 6 
E23..11 Alcoholism No 6 
136A.00 Ex-trivial drinker (<1u/day) Yes 5 
136M.00 Current non drinker No 3 
136W.00 Alcohol misuse No 2 
136d.00 Lower risk drinking Yes 2 
1462.00 H/O: alcoholism No 2 
E231z00 Chronic alcoholism NOS No 2 
E250.00 Nondependent alcohol abuse No 2 
136Q.00 Very heavy drinker Yes 1 
136c.00 Higher risk drinking Yes 1 
E230.00 Acute alcoholic intoxication in alcoholism No 1 
E23z.00 Alcohol dependence syndrome NOS No 1 
E250000 Nondependent alcohol abuse, unspecified No 1 
E250200 Nondependent alcohol abuse, episodic No 1 
Eu10100 [X]Mental and behav dis due to use of alcohol: harmful use No 1 
Eu10211 [X]Alcohol addiction No 1 
136Y.00 Drinks in morning to get rid of hangover No 0 
136a.00 Increasing risk drinking Yes 0 
136b.00 Feels should cut down drinking No 0 
E230.11 Alcohol dependence with acute alcoholic intoxication No 0 
E230000 Acute alcoholic intoxication, unspecified, in alcoholism No 0 
E230100 Continuous acute alcoholic intoxication in alcoholism No 0 
E230200 Episodic acute alcoholic intoxication in alcoholism No 0 
E230300 Acute alcoholic intoxication in remission, in alcoholism No 0 
E230z00 Acute alcoholic intoxication in alcoholism NOS No 0 
E231.00 Chronic alcoholism No 0 
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E231.11 Dipsomania No 0 
E231000 Unspecified chronic alcoholism No 0 
E231100 Continuous chronic alcoholism No 0 
E231200 Episodic chronic alcoholism No 0 
E231300 Chronic alcoholism in remission No 0 
E250100 Nondependent alcohol abuse, continuous No 0 
E250300 Nondependent alcohol abuse in remission No 0 
E250z00 Nondependent alcohol abuse NOS No 0 
Eu10200 [X]Mental and behav dis due to use alcohol: dependence syndr No 0 
Eu10212 [X]Chronic alcoholism No 0 
Eu10213 [X]Dipsomania No 0 
ZV11300 [V]Personal history of alcoholism No 0 
*In QOF = Included in the list of codes eligible for recompense in the Quality and Outcomes Framework Pay for Performance 
Scheme for alcohol screening in people with severe mental illness 
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Appendix 2 
 
Read codes for screening and frequency of use among people with schizophrenia in 
April 2011-March 2013 
 Read code Description N 
9k17.00 Alcohol screen - AUDIT C completed 263 
9k16.00 Alcohol screen - fast alcohol screening test completed 117 
68S..00 Alcohol consumption screen 67 
9k13.00 Alcohol questionnaire completed 36 
9k15.00 Alcohol screen - AUDIT completed 35 
38D3.00 Alcohol use disorders identification test 28 
6892.00 Alcohol consumption screen 16 
388u.00 Fast alcohol screening test 12 
38D4.00 Alcohol use disorder identificatn test consumptn questionnre 5 
ZR1F.11 AUDIT - Alcohol use disorders identification test 4 
ZR1F.00 Alcohol use disorders identification test 2 
ZRLfD00 Hlth Nat Outcome Scale item 3 2 
38Dz.00 Severity of alcohol dependence questionnaire 1 
388j.00 Cage questionnaire 0 
38D2.00 Single alcohol screening questionnaire 0 
38D5.00 Alcoh use disor id test Piccinelli consumption questionnaire 0 
38Df.00 Five-shot questionnaire on heavy drinking 0 
38Dz.11 SADQ - Severity of alcohol dependence questionnaire 0 
9k18.00 Alcohol screen - AUDIT PC completed 0 
ZR1E.00 Alcohol dependence scale 0 
ZR1E.11 ADS - Alcohol dependence scale 0 
ZR1G.00 Alcohol use inventory 0 
ZR31.00 Cage questionnaire 0 
ZR3f.00 Comprehensive drinker profile 0 
ZR3f.11 CDP - Comprehensive drinker profile 0 
ZRBJ.00 Drinking problem scale 0 
ZRBJ.11 DPS - Drinking problem scale 0 
ZRLfD11 HoNOS item 3 0 
ZRLfD12 HoNOS item 3 - alcohol/drug problem 0 
ZRR..00 Inventory of drinking situations 0 
ZRVK.00 Last six months of drinking questionnaire 0 
ZRa1.00 Michigan alcoholism screening test 0 
ZRa1.11 MAST - Michigan alcoholism screening test 0 
ZRa1100 Brief Michigan alcoholism screening test 0 
ZRa1111 BMAST - Brief Michigan alcoholism screening test 0 
ZRa1200 Short Michigan alcoholism screening test 0 
ZRa1211 SMAST - Short Michigan alcoholism screening test 0 
ZRaU.00 Munich alcoholism test 0 
ZRaU.11 MALT - Munich alcoholism test 0 
ZRk6.00 Severity of alcohol dependence questionnaire 0 
ZRk6.11 SADQ - Severity of alcohol dependence questionnaire 0 
ZRk9.00 Short alcohol dependence data 0 
ZRk9.11 SADD - Short alcohol dependence data 0 
ZV79100 [V]Screening for alcoholism 0 
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